Morning Overview on MSN
The FDA cleared its first blood test to flag prostate cancer in men with high PSA
An elevated PSA reading has long put men in an uncomfortable position: it signals possible prostate cancer, but it is ...
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who ...
Researchers have developed a fully human antibody that suppressed tumor growth and metastatic spread in preclinical models of ...
Prostate Cancer UK have paid tribute to broadcaster Dermot Murnaghan, describing him as a "passionate and dedicated supporter" of the charity. The charity said his decision to share his diagnosis ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results